D5 Therapeutics
Seongnam
About D5 Therapeutics
D5 Therapeutics is a biotechnology company that focuses on developing innovative medicines in the context of synthetic lethality. The company employs the synthetic lethality conceptual framework, leveraging data-driven platform technology to enable medical researchers to develop novel targets and innovative medicines with anticancer drugs to treat people.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Total funding: $3.0M
- Funding stage: Seed
- Last round: Seed (Sep 2023)
- Website: d5tx.com
- Phone: 031-759-9920
Industries & Categories
Biotechnology, Pharmaceutical, Therapeutics
Canonical: https://fsome.com/organization/d5-therapeutics-78409 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.